The study team applied single-cell RNA sequencing to a zebrafish model of wounding-induced inflammation to map transcriptional states across skin and leukocytes. The investigators reported inflammation-specific cell populations arising within the epidermis and among myeloid lineages. Some epidermal clusters were exclusive to the inflamed condition and expressed elevated inflammatory markers; similarly, distinct macrophage and neutrophil subsets appeared only after wounding. The source did not provide experimental details such as sequencing depth, exact timepoints after injury, or cell counts per cluster.
Single-cell resolution allowed the authors to link differentiation states with hormone responsiveness. The authors emphasized that the ubiquitous expression of the glucocorticoid receptor across tissues does not imply uniform transcriptional outcomes; rather, inflammation redirected both epidermal and leukocyte differentiation trajectories, creating subpopulations with divergent signaling phenotypes.
Investigators tested GR-mediated transcriptional regulation under inflammatory conditions using dexamethasone as the activating ligand. They observed a reduced GR transactivation response in the inflammation-specific epidermal cells compared with non-inflamed counterparts. Short statement: epidermal inflammatory subsets showed blunted dexamethasone-driven transcription.
The cohort of macrophages that emerged during inflammation likewise displayed diminished activation by dexamethasone. The study team observed this parallel between epidermal inflammatory cells and macrophages, suggesting a shared alteration in GR responsiveness across these cell types under local inflammatory signaling.
Neutrophils behaved differently. The inflammation-specific neutrophil subset retained responsiveness to dexamethasone, according to the reported single-cell transcriptional readouts. This contrast—macrophages and epidermal cells losing transactivation while neutrophils keep it—points to cell-intrinsic regulatory differences rather than a blanket suppression of GR signaling within the injured tissue.
The authors reported transcriptional readouts of GR activation at single-cell level but did not list specific GR target genes or provide quantitative effect sizes for the loss of transactivation in the public source text. Dosing regimen for dexamethasone, exposure duration, and timing relative to wounding were not reported in the source material.
To investigate mechanisms behind the cell-selective GR responses, the authors correlated dexamethasone responsiveness with the expression of putative transcriptional coregulators across cell clusters. From these correlations they identified candidate regulators that may tune GR activity in a cell-type–specific manner. The study team presented these candidates as potential mechanistic links between inflammatory differentiation states and altered steroid responsiveness.
The report did not, however, provide functional validation of individual coregulators in vivo; the source described correlations and candidate identification rather than knockdown, overexpression, or biochemical interaction experiments. Therefore the mechanistic assignments remain hypotheses derived from transcriptional covariance rather than proven causal relationships.
The authors made clear observations about cell-type–specific changes in GR signaling during a local inflammatory response, but several experimental details are missing from the source text. The report did not specify the concentration or dosing schedule of dexamethasone, the precise timepoints sampled after wounding, nor the sequencing metrics and cluster sizes used to define inflammation-specific populations. The source also did not report direct functional assays confirming that altered transactivation translated into changed cell behavior in vivo beyond transcriptional signatures.
Open questions emerging from the dataset include whether the identified transcriptional coregulators causally determine GR responsiveness in each cell type, how transient or stable the inflammation-specific differentiation states are, and whether similar cell-type–selective steroid resistance occurs in mammalian skin and myeloid cells. The authors offered candidate mechanisms grounded in correlated expression, but further experimental validation—such as targeted perturbation of coregulators or longitudinal sampling after injury—would be required to move from correlation to causation.
The dataset nonetheless provides a detailed single-cell snapshot that links local inflammation to altered hormone signaling. Investigators interested in steroid pharmacodynamics, wound immunobiology, or cell differentiation can use the reported candidates as starting points. The source text is explicit about the scope of the reported findings: transcriptional characterization and candidate identification. It does not claim functional validation beyond those transcriptional correlations, nor does it report precise experimental parameters for treatment and sampling that readers might need to reproduce the work.